This included confirmed partial responses in two patients: one with endometrial adenocarcinoma harboring a PIK3R2 alteration, and one with ovarian carcinoma harboring a PIK3CA and PTEN alterations. Here, PIK3R2 is linked to ovarian carcinoma.